Hospital General de Agudos Dr. J. M. Ramos Mejia

Ciudad Autonoma, Buenos Aires, C1221ADC

2 studies enrolling now · 7 studies all time

What they study most

COVID-19, Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH), Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis — Recruiting now
• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis — Recruiting now
• An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients — Completed
• Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients — Completed
• A Phase II Study of M2951 in SLE — Stopped early
• Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis — Completed
• A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors — Completed